NCT04157231

Brief Summary

An investigator-initiated, evaluator-blinded, prospective, multi centre, before-and-after, effectiveness-implementation hybrid design study to assess the feasibility of essential acute stroke care in a low resource setting

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
2 countries

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Dec 2025Dec 2027

First Submitted

Initial submission to the registry

November 4, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
6.1 years until next milestone

Study Start

First participant enrolled

December 30, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

1.5 years

First QC Date

November 4, 2019

Last Update Submit

March 3, 2025

Conditions

Keywords

StrokeIschemic strokehemorrhagic strokestroke package

Outcome Measures

Primary Outcomes (1)

  • Adherence

    Primary Outcome Measure: Adherence to the predefined components of the essential acute stroke care management plan Adherence will be expressed as all or none measure and is defined as the proportion of patients who receive all the components of acute stroke care management for which the patient is eligible. Adherence will also be expressed as a composite measure, which is defined as the total number of eligible components performed divided by the total number of components for which the patient was eligible.

    30 days

Secondary Outcomes (1)

  • Death or disability

    30 Days

Study Arms (2)

Usual Care

NO INTERVENTION

Usual care to be provided to patients as per hospital guidelines for 3 months

Intervention arm

OTHER

The intervention consists of training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. This intervention will run for 3 months. Refresher training will be given monthly during the intervention.

Other: Acute stroke care Intervention arm

Interventions

Training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. The aim of these sessions will be to educate stroke champions and other site staff on the management protocols. Available training resources will be accessed (including online materials) and simulation training will be used. New skills such as dysphagia assessment will be emphasized based on existing knowledge and competencies. After training, staff will have another assessment (Post-test) in order to determine whether they have been adequately trained and are able to adhere to the essential acute stroke care management plan. A standardised Power Point presentation and accompanying handouts will be made available for further use in the ward. Refresher training will be provided monthly during the intervention.

Intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (age ≥18 years)
  • A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset
  • Provision of written informed consent
  • Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.

You may not qualify if:

  • Patients who have undergone intravenous thrombolysis or mechanical thrombectomy
  • Patients who are planned for transfer to the intensive care unit
  • Subarachnoid haemorrhage
  • Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Murtala Muhammad Specialist Hospital

Kano, Kano State, 3200, Nigeria

Location

Federal Medical Centre

Lokoja, Kogi State, 1001, Nigeria

Location

Hospital de Apoyo II-2 Sullana

Piura, Peru

Location

Hospital de la Amistad Peru Corea Santa Rosa II-2

Piura, Peru

Location

MeSH Terms

Conditions

StrokeIschemic StrokeHemorrhagic Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Carlos Abanto, Dr

    National Institute of Neurological Sciences, Lima, Peru

    PRINCIPAL INVESTIGATOR
  • Kolawawole Wahab, Professor

    University of Ilorin & University of Ilorin Teaching Hospital Ilorin, Nigeria

    PRINCIPAL INVESTIGATOR
  • Hasan Farhan, Professor

    President of Iraqi Scientific Council of Cardiology,Iraq

    PRINCIPAL INVESTIGATOR
  • Yi Sui, Dr

    Shenyang First People's Hospital Hospital Affiliated Brain Hospital

    PRINCIPAL INVESTIGATOR
  • Saima Hilal, A/Professor

    National University of Singapore

    PRINCIPAL INVESTIGATOR
  • Lily Song, Dr

    The George Institute of Global Health, China

    PRINCIPAL INVESTIGATOR
  • Craig Anderson, Professor

    Executive Director The George Institute for Global Health - China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The clinical outcome will be assessed by a blinded assessor
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: A before and after, effectiveness-implementation hybrid study design with blinded outcome assessment will be conducted. This type 1 effectiveness-implementation hybrid design will test the essential acute stroke care management plan and secondarily gather data to inform subsequent research trials
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2019

First Posted

November 8, 2019

Study Start

December 30, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Requests for access to the de-identified data that underlie the study results should be made to: datasharing@georgeinstitute.org. We will provide data to researchers with a methodologically sound proposal, and will work with interested parties to define and operationalise a data access agreement.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will be available after publication of the main paper

Locations